The National Antimicrobial Resistance Monitoring System
The National Antimicrobial Resistance Monitoring System (NARMS) was established in 1996. NARMS is a collaborative program of state and local public health departments and universities, the FDA, the Centers for Disease Control and Prevention (CDC), and the U.S. Department of Agriculture (USDA). This national public health surveillance system tracks changes in the antimicrobial susceptibility of enteric (intestinal) bacteria found in ill people (CDC), retail meats (FDA), and food animals (USDA) in the United States. The NARMS program helps promote and protect public health by providing information about emerging bacterial resistance, how resistant infections differ from susceptible infections, and the impact of interventions designed to limit the spread of resistance. NARMS data are used by FDA to make regulatory decisions designed to preserve the effectiveness of antibiotics for humans and animals.
July 5, 2022 - FDA Announces 2022 Public Meeting of the National Antimicrobial Resistance Monitoring System
April 19, 2022 - FDA Releases NARMS Integrated Summary 2019
December 11, 2020 - FDA Releases 2018 NARMS Integrated Summary and NARMS Now: Integrated Data Featuring Genomic Data and Predicted Resistance
August 18, 2020 - FDA Releases NARMS Strategic Plan, Announces October 2020 NARMS Virtual Public Meeting